The common mucosal immune system response results in antibody production and cellular immune functions at portals of entry for microbial pathogens. Antibodies elicited by natural infections or induced by vaccines have been demonstrated in mucosal secretions and have been shown to correlate with protection against challenge viruses. Antibodies to human immunodeficiency virus (HIV) have been demonstrated in saliva, semen, colostrum, milk, and in rectal or genital secretions of infected patients. However, the source (mucosal or systemic), isotype, protein targets, and functions of local antibodies to HIV are poorly defined. Because of the possible role of mucosal antibodies in preventing mucosal HIV infection, a better understanding of mucosal immunity is important for developing effective vaccines. Yet, mucosal antibodies are difficult to sample and to measure. We have developed reproducible sampling methods and extremely sensitive protein-specific IgG-, IgA-, and IgM- detection techniques (including enhanced chemiluminescent-immunoblot or """"""""ECL-WB"""""""" and enzyme immunoassays or """"""""ECL-EIA"""""""") for antibodies cervical, rectal, and salivary secretions. ECL-WB and ECL-EIA will be used to quantitate isotype-specific mucosal HIV antibody responses to denatured or native HIV proteins, respectively. Local antibody titers will be compared with HIV titers and with cellular immune functions (from the collaborative project) in local and peripheral blood compartments to determine the extent and mechanism of immune viral clearance. Local IgG- and IgA-mediated neutralizing antibodies will be measured in patients with recent or long-standing HIV infections against autologous HIV strains from peripheral blood and mucosal sites and against prototype strains to determine the strain-related variability of local functional antibodies. Finally, HIV protein-specific, isotype-specific, and neutralizing antibodies to HIV will be measured in pre- and postnatal cervical secretions of HIV-infected Seattle mothers and in milk samples from African mothers to determine the correlation of antibodies in cervix or milk with intrapartum or neonatal transmission, respectively. These studies will provide a systematic description of the local antibodies elicited by HIV infection. Correlation with local cellular functions and with HIV strain and titer (as determined in the collaborative project) will promote understanding of virus-host interaction via the mucosal immune system.

Project Start
Project End
Budget Start
Budget End
Support Year
5
Fiscal Year
1995
Total Cost
Indirect Cost
Name
Seattle Children's Hospital
Department
Type
DUNS #
048682157
City
Seattle
State
WA
Country
United States
Zip Code
98105
Schiffer, Joshua T; Swan, Dave A; Roychoudhury, Pavitra et al. (2018) A Fixed Spatial Structure of CD8+ T Cells in Tissue during Chronic HSV-2 Infection. J Immunol 201:1522-1535
Traidl, Stephan; Kienlin, Petra; Begemann, Gabriele et al. (2018) Patients with atopic dermatitis and history of eczema herpeticum elicit herpes simplex virus-specific type 2 immune responses. J Allergy Clin Immunol 141:1144-1147.e5
Ramchandani, Meena; Selke, Stacy; Magaret, Amalia et al. (2018) Prospective cohort study showing persistent HSV-2 shedding in women with genital herpes 2 years after acquisition. Sex Transm Infect 94:568-570
Boucoiran, Isabelle; Mayer, Bryan T; Krantz, Elizabeth M et al. (2018) Nonprimary Maternal Cytomegalovirus Infection After Viral Shedding in Infants. Pediatr Infect Dis J 37:627-631
Kleinstein, Sarah E; Shea, Patrick R; Allen, Andrew S et al. (2018) Genome-wide association study (GWAS) of human host factors influencing viral severity of herpes simplex virus type 2 (HSV-2). Genes Immun :
Gilbert, Peter B; Excler, Jean-Louis; Tomaras, Georgia D et al. (2017) Antibody to HSV gD peptide induced by vaccination does not protect against HSV-2 infection in HSV-2 seronegative women. PLoS One 12:e0176428
Celum, Connie; Hong, Ting; Cent, Anne et al. (2017) Herpes Simplex Virus Type 2 Acquisition Among HIV-1-Infected Adults Treated With Tenofovir Disoproxyl Fumarate as Part of Combination Antiretroviral Therapy: Results From the ACTG A5175 PEARLS Study. J Infect Dis 215:907-910
Abana, Chike O; Pilkinton, Mark A; Gaudieri, Silvana et al. (2017) Cytomegalovirus (CMV) Epitope-Specific CD4+ T Cells Are Inflated in HIV+ CMV+ Subjects. J Immunol 199:3187-3201
Johnston, Christine; Magaret, Amalia; Roychoudhury, Pavitra et al. (2017) Highly conserved intragenic HSV-2 sequences: Results from next-generation sequencing of HSV-2 UL and US regions from genital swabs collected from 3 continents. Virology 510:90-98
Agyemang, Elfriede; Le, Quynh-An; Warren, Terri et al. (2017) Performance of Commercial Enzyme-Linked Immunoassays for Diagnosis of Herpes Simplex Virus-1 and Herpes Simplex Virus-2 Infection in a Clinical Setting. Sex Transm Dis 44:763-767

Showing the most recent 10 out of 345 publications